It is unlikely that the regional differences in the frequency of TSC1 patients mean that the barriers to brain imaging diagnosis were low in Japan for national medical insurance, so it is likely that TSC patients with milder phenotypes were more frequently diagnosed. The gene discussed is TSC1; the disease is tuberous sclerosis.